120 related articles for article (PubMed ID: 9105881)
1. Differential effects of isoliquiritigenin and YC-1 in rat aortic smooth muscle.
Wegener JW; Nawrath H
Eur J Pharmacol; 1997 Mar; 323(1):89-91. PubMed ID: 9105881
[TBL] [Abstract][Full Text] [Related]
2. Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.
Yu SM; Kuo SC
Br J Pharmacol; 1995 Apr; 114(8):1587-94. PubMed ID: 7599926
[TBL] [Abstract][Full Text] [Related]
3. Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat.
Wegener JW; Gath I; Förstermann U; Nawrath H
Br J Pharmacol; 1997 Dec; 122(7):1523-9. PubMed ID: 9421305
[TBL] [Abstract][Full Text] [Related]
4. Cardiac effects of isoliquiritigenin.
Wegener JW; Nawrath H
Eur J Pharmacol; 1997 May; 326(1):37-44. PubMed ID: 9178653
[TBL] [Abstract][Full Text] [Related]
5. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
[TBL] [Abstract][Full Text] [Related]
6. Involvement of K(+) channels in the relaxant effects of YC-1 in vascular smooth muscle.
Seitz S; Wegener JW; Rupp J; Watanabe M; Jost A; Gerhard R; Shainberg A; Ochi R; Nawrath H
Eur J Pharmacol; 1999 Oct; 382(1):11-8. PubMed ID: 10556499
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
Teixeira CE; Priviero FB; Webb RC
J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
[TBL] [Abstract][Full Text] [Related]
8. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
[TBL] [Abstract][Full Text] [Related]
9. YC-1 potentiates the nitric oxide/cyclic GMP pathway in corpus cavernosum and facilitates penile erection in rats.
Hsieh GC; O'Neill AB; Moreland RB; Sullivan JP; Brioni JD
Eur J Pharmacol; 2003 Jan; 458(1-2):183-9. PubMed ID: 12498924
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of carbon monoxide-induced relaxation of rat aorta by YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole].
McLaughlin BE; Chretien ML; Choi C; Brien JF; Nakatsu K; Marks GS
Can J Physiol Pharmacol; 2000 Apr; 78(4):343-9. PubMed ID: 10772062
[TBL] [Abstract][Full Text] [Related]
11. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
[TBL] [Abstract][Full Text] [Related]
12. Effects of cyclic GMP elevation on isoprenaline-induced increase in cyclic AMP and relaxation in rat aortic smooth muscle: role of phosphodiesterase 3.
Delpy E; Coste H; Gouville AC
Br J Pharmacol; 1996 Oct; 119(3):471-8. PubMed ID: 8894166
[TBL] [Abstract][Full Text] [Related]
13. A-350619: a novel activator of soluble guanylyl cyclase.
Miller LN; Nakane M; Hsieh GC; Chang R; Kolasa T; Moreland RB; Brioni JD
Life Sci; 2003 Jan; 72(9):1015-25. PubMed ID: 12495780
[TBL] [Abstract][Full Text] [Related]
14. Relaxant effects of the soluble guanylate cyclase activator and NO sensitizer YC-1 in piglet pulmonary arteries.
González-Luis G; Cogolludo A; Moreno L; Lodi F; Tamargo J; Pérez-Vizcaíno F; Villamor E
Biol Neonate; 2006; 90(1):66-72. PubMed ID: 16534188
[TBL] [Abstract][Full Text] [Related]
15. Enhanced responsiveness to nitric oxide, nitroxyl anions, and nitrergic transmitter by 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole in the rat anococcygeus muscle.
Che Y; Ellis A; Li CG
Nitric Oxide; 2005 Sep; 13(2):118-24. PubMed ID: 15993633
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
Yu SM; Cheng ZJ; Kuo SC
Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
[TBL] [Abstract][Full Text] [Related]
17. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase.
Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of anti-proliferation caused by YC-1, an indazole derivative, in cultured rat A10 vascular smooth-muscle cells.
Yu SM; Cheng ZJ; Guh JH; Lee FY; Kuo SC
Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):787-92. PubMed ID: 7702575
[TBL] [Abstract][Full Text] [Related]
19. YC-1 potentiates the antiplatelet effect of hydrogen peroxide via sensitization of soluble guanylate cyclase.
Wu CC; Kuo SC; Lee FY; Teng CM
Eur J Pharmacol; 1999 Sep; 381(2-3):185-91. PubMed ID: 10554886
[TBL] [Abstract][Full Text] [Related]
20. Characterization of NS 2028 as a specific inhibitor of soluble guanylyl cyclase.
Olesen SP; Drejer J; Axelsson O; Moldt P; Bang L; Nielsen-Kudsk JE; Busse R; Mülsch A
Br J Pharmacol; 1998 Jan; 123(2):299-309. PubMed ID: 9489619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
